Cutera (NASDAQ:CUTR) Earns Sell Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of Cutera (NASDAQ:CUTR) in a research report report published on Saturday morning. The firm issued a sell rating on the medical device company’s stock.

Cutera Trading Down 63.9 %

Cutera stock opened at $0.04 on Friday. The stock has a market capitalization of $787,254.00, a price-to-earnings ratio of -0.01 and a beta of 1.36. The stock has a 50 day moving average of $0.15 and a two-hundred day moving average of $0.36. Cutera has a twelve month low of $0.09 and a twelve month high of $3.00.

Hedge Funds Weigh In On Cutera

A hedge fund recently raised its stake in Cutera stock. Geode Capital Management LLC raised its holdings in Cutera, Inc. (NASDAQ:CUTR) by 25.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 248,257 shares of the medical device company’s stock after purchasing an additional 50,046 shares during the quarter. Geode Capital Management LLC owned 1.23% of Cutera worth $88,000 as of its most recent filing with the Securities and Exchange Commission. 90.70% of the stock is owned by hedge funds and other institutional investors.

Cutera Company Profile

Cutera, Inc provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform.